Nexien BioPharma
(OTC) NXEN
Nexien BioPharma Financials at a Glance
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$188.08K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-2.05 (Low)
Dividend
$0.00
Beta (Volatility)
-2.05 (Low)
Price
$0.00
Volume
5
Open
$0.00
Price
$0.00
Volume
5
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Estimated Earnings Date
May 12, 2026
Dividend
$0.00
Beta (Volatility)
-2.05 (Low)
Price
$0.00
Volume
5
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Estimated Earnings Date
May 12, 2026
NXEN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nexien BioPharma
Industry
Pharmaceuticals
Sector
Health CareCEO
Richard Greenberg
Website
www.nexienbiopharma.comHeadquarters
Glendale, CO 80246, US
NXEN Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
77.94%
Return on Capital
N/A
Return on Assets
-5713.60%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
70.77M
Volume
5
Avg. Volume
333.613
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$118.32K
EBITDA
-$64.29K
Operating Cash Flow
-$61.78K
Capital Expenditure
$1.00
Free Cash Flow
-$61.78K
Cash & ST Invst.
$8.29K
Total Debt
$375.38K
Nexien BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$710.00
N/A
Employees
10
N/A
Net Income
-$30.09K
+43.4%
EBITDA
$0.00
N/A
Quarterly Fundamentals
Total Cash
$8.29K
-17.7%
Total Debt
$375.38K
+27.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$375.38K
+27.2%
Return on Assets
-57.14%
N/A
Return on Invested Capital
43.18%
N/A
Free Cash Flow
-$13.02K
+37.9%
Operating Cash Flow
-$13.02K
+37.9%